These same authors suggested that increased IGF2R protein expression in endometrial cells in T2DM patients could increase PI3K/cyclin D1 (CCND1)-dependent cell growth through the loss of competitive binding of IGF2 to IGF1R, a possible explanation for the higher risk of developing EC in T2DM. The gene discussed is IGF2; the disease is type 2 diabetes mellitus.